NCT01813253 2018-03-26
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer
Kuhnil Pharmaceutical Co., Ltd.
Phase 3 Terminated
Clinical Trials
5 trialsNCT00983047 2015-08-27
Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 2 Terminated
NCT01382745 2013-01-28
Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Terminated
NCT00369447 2011-07-01
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer
YM BioSciences
Phase 1/2 Terminated
NCT00872482 2011-07-01
A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
YM BioSciences
Phase 2 Terminated